By Joyce Lee
The ability to predict the onset of Alzheimer’s disease dementia from simple blood tests in cognitively healthy individuals might soon become a reality, a recent New York Times column suggests.
But Alzheimer’s is a disease currently with no successful prevention method, and so this kind of test raises a critical question: how will people who test positive for biomarkers of Alzheimer’s disease understand and grapple with such sensitive health information, and what can physicians, policymakers, and the wider community do to help them make sense of this information?